In the third installment of our exclusive analysis, led by Germán Chaparro of Proyekta Data Solutions, we shift our focus to the supplier side: Colombia’s medical device and equipment industry. Based on a consolidated study of 70 representative companies, the data reveals how the liquidity crisis plaguing hospitals and insurers has ultimately reached international manufacturers and distributors.
For parent companies, understanding the systemic risk of this market has become essential. A distributor’s strength can no longer be measured solely by its individual efficiency, but rather by the broader healthcare system’s ability to generate cash.
1. Stagnant Growth: The Inability to Adjust Prices
The financial deterioration of hospitals has triggered a domino effect that is stifling growth across the MedTech sector. Companies are facing severe difficulties in adjusting prices for their supplies and equipment, driven entirely by the lack of liquidity among their clients (IPSs, or private healthcare providers).
- Stagnant sales: Between 2023 and 2025, industry sales hovered in a narrow range of $2.62 billion to $2.72 billion USD.
- The inflationary impact: This represents a mere 3.8% growth over a three-year period—a concerningly low figure when considering that annual inflation ran at 9.3%, 5.2%, and 5.1%, respectively.
- The size gap: Large enterprises (21 companies) managed to grow by 4.7% in 2025, whereas micro, small, and medium-sized businesses barely scraped by with a 1.6% increase.
Top 5 Revenue in the Industry for 2025
| Company | 2025 Revenue (USD) |
| Abbott | $279.74 million |
| Johnson & Johnson | $248.80 million |
| Baxter | $187.10 million |
| Medtronic | $184.42 million |
| Messer | $141.88 million |
2. Colombia vs. Other Emerging Markets
When comparing the financial performance of Colombia’s medical device and equipment industry against other emerging economies, stark profitability gaps emerge:
Financial Indicators (2025)
| Financial Indicator (2025) | Colombia (Devices & Equipment) | Emerging Markets Benchmark |
| Growth Rate (last 5 years) | 8.6% 🔴 | 9.2% 🟢 |
| EBITDA Margin | 14.2% 🔴 | 16.2% 🟢 |
| Net Margin | 4.4% 🔴 | 10.0% 🟢 |
| Enterprise Value / Sales (EV Multiple) | 0.5x | 4.5x |
3. An Industry in Transition: From Maturity to Innovation
Based on the industrial life cycle (SBC) methodology, Colombia’s MedTech sector is transitioning between relative decline (“Fade”) and maturity. The market is currently characterized by conservative financial strategies, moderate growth rates, and mounting pressure on profit margins.
In this environment, the primary threats and opportunities for medical device companies are clear:
- Critical threats: A sharp drop in technology investments by hospitals and an alarming spike in Days Sales Outstanding (DSO), which now average 160 days.
- Strategic opportunities: Technological innovation—such as artificial intelligence, robotic surgery, and remote monitoring—continues to unlock new avenues for growth. Furthermore, because hospitals lack the liquidity to purchase new capital equipment, there is surging market demand for maintenance, upgrades, and long-term service contracts.
Conclusion and Strategic Recommendations for Parent Companies
In today’s ecosystem, the financial sustainability of local MedTech distributors relies less on their own operational efficiency and more on structural bottlenecks that choke payments nationwide. Applying uniform corporate policies across all global markets—while ignoring Colombia’s specific liquidity crisis—drastically increases the risk of insolvency for strategic partners and threatens to disrupt the entire supply chain.
International parent companies need to adopt a comprehensive approach to assessing systemic risk in the Colombian market. This means actively adjusting credit policies, offering flexibility on inventory levels, and setting realistic growth targets to safeguard long-term relationships with local distributors.
Methodological Note: All amounts stated in this article are in U.S. dollars (USD). Data originally in Colombian pesos were converted using a standard reference rate.
Next Steps
Contact GHI to explore these financial challenges in greater depth, presented in collaboration with Proyekta Data Solutions. Discover how you can adjust your market access strategy, structure secure financing models, and manage credit risk by effectively connecting with healthcare providers in Latin America. Our research team is ready to equip your organization with the strategic regional intelligence and supply chain analysis you need to gain invaluable insights and support smarter corporate decision-making.
